Managing epilepsy in tuberous sclerosis complex.

Area of Science:

• Neurology
• Genetics
• Pediatrics

Background:

• Epilepsy is a highly prevalent neurological disorder in tuberous sclerosis complex (TSC), affecting 80-90% of individuals.
• Onset typically occurs in childhood, with up to one-third of TSC patients developing infantile spasms.
• The neuropathology of TSC, including cortical tubers and dysgenetic features, is believed to contribute to epilepsy incidence.

Purpose of the Study:

• To summarize the epidemiology, clinical features, and management strategies for epilepsy in tuberous sclerosis complex.
• To highlight effective treatments for infantile spasms and pharmacoresistant epilepsy in TSC patients.

Main Methods:

• Literature review of epilepsy in tuberous sclerosis complex.
• Analysis of treatment modalities including anticonvulsant medications, vagus nerve stimulator, ketogenic diet, and epilepsy surgery.
• Evaluation of specific drug efficacy, such as Vigabatrin for infantile spasms.

Main Results:

• Epileptiform features on electroencephalograms are common in individuals with TSC.
• Vigabatrin demonstrates particular effectiveness in treating infantile spasms associated with TSC.
• Epilepsy surgery plays a crucial role in managing pharmacoresistant epilepsy in both pediatric and adult TSC populations.

Conclusions:

• Epilepsy is a major comorbidity in TSC requiring comprehensive management strategies.
• Current treatments are similar to other epilepsy causes, with specific effective options for TSC-related seizures.
• Further research into the underlying mechanisms and optimal treatment protocols for TSC-associated epilepsy is warranted.